Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia
M. Ghanem (Paris, France), M. Homps-Legrand (Paris, France), L. Morer (Paris, France), T. Goletto (Paris, France), J. Frija (Paris, France), C. Bancal (Paris, France), M. Hurtado-Nedelec (Paris, France), M. Jaillet (Paris, France), A. Mailleux (Paris, France), C. Neukirch (Paris, France), R. Borie (Paris, France), C. Taille (Paris, France), B. Crestani (Paris, France)
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 642
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ghanem (Paris, France), M. Homps-Legrand (Paris, France), L. Morer (Paris, France), T. Goletto (Paris, France), J. Frija (Paris, France), C. Bancal (Paris, France), M. Hurtado-Nedelec (Paris, France), M. Jaillet (Paris, France), A. Mailleux (Paris, France), C. Neukirch (Paris, France), R. Borie (Paris, France), C. Taille (Paris, France), B. Crestani (Paris, France). Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia. 642
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: